Skip to main content
The Cochrane Database of Systematic Reviews logoLink to The Cochrane Database of Systematic Reviews
. 2015 Jun 5;2015(6):CD004193. doi: 10.1002/14651858.CD004193.pub3

Anticholinergics for urinary symptoms in multiple sclerosis

Richard S Nicholas 1,, Tim Friede 2, Sally Hollis 3, Carolyn A Young 4
Editor: Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
PMCID: PMC10666567  PMID: 26043867

Reason for withdrawal from publication

This review has been withdrawn for the following reasons:

a review author contravenes Cochrane's Commercial Sponsorship Policy. This policy ensures the independence of Cochrane reviews by making sure that there is no bias associated with commercial conflicts of interest in the conduct of Cochrane reviews. The author was employed by the biopharmaceutical company AstraZeneca and cannot say with certainty that the company did not produce or have any financial interest in the interventions in this review

the review is substantially out of date

To view the published versions of this article, please click the 'Other versions' tab.

The editorial group responsible for this previously published document have withdrawn it from publication.

What's new

Date Event Description
19 May 2008 Amended Converted to new review format.

Withdrawn from publication for reasons stated in the review


Articles from The Cochrane Database of Systematic Reviews are provided here courtesy of Wiley

RESOURCES